Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: An investigation into the preferences and information needs of women

Prenatal Diagnosis

Volumn 33, Issue 7, 2013, Pages 688-694

  Oxenford, Kerry ^a   Silcock, Caroline ^a   Hill, Melissa ^a,b   Chitty, Lyn ^a,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL FREE FETAL DNA; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

ACCESS TO INFORMATION; ACCURACY; ARTICLE; BLOOD GROUP; FEMALE; FETUS; GENOTYPE; HEALTH CARE DELIVERY; HUMAN; INTERVIEW; KNOWLEDGE; NEEDS ASSESSMENT; PATIENT EDUCATION; PATIENT PREFERENCE; PRENATAL PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE;

BLOOD GROUPING AND CROSSMATCHING; DNA; FEMALE; FETAL BLOOD; GENOTYPE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDWIFERY; PATIENT EDUCATION AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 84880036229     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4135     Document Type: Article

References (20)

1. National Institute for Clinical Excellence (NICE). Technology appraisal guidance 41. Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. London: NICE, 2002.
2. Daniels G. Human Blood Groups, (2nd edn) Oxford: Blackwell Science, 2002.
3. Kumpel BM. Monoclonal anti-D development programme. Transpl Immunol 2002;10:199-204.
4. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish hepatology research group. N Engl J Med 1999;340:1228-33.
5. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
6. Daniels G, Finning K, Martin P, Massey E. Non-invasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 2009;29:101-7.
7. Finning K, Martin P, Summers J, et al. Effect of high through put RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-8.
8. Chitty LS, Finning K, Massey E, et al. Antenatal determination of fetal Rhesus (RH) D status using cell-free fetal DNA in the maternal circulation before 20weeks gestation: is routine application practical and beneficial? Arch Dis Child Fetal Neonatal Ed 2011;96(Suppl 1):Fa11-Fa12.
9. Clausen FB, Christiansen M, Steffensen R, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:752-8.
10. National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 156. Routine antenatal anti-D prophylaxis for women who are Rhesus D negative. London: NICE; 2008 [Accessed 13/04/2012]; Available from: http://www.nice.org.uk/nicemedia/live/12047/41690/41690.pdf.
11. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
12. Chitty LS, Finning K, Wade A, et al. Routine fetal RHD typing using cffDNA in RhD negative women: timing, costs and efficiency. Prenat Diagn 2012;32 (Suppl 1):58-9.
13. Lewis C, Hill M, Skirton H, Chitty L. Non-invasive prenatal diagnosis for fetal sexing - what is the value for service users? Eur J Hum Genet 2012;20:1127-33.
14. Lewis C, Hill M, Skirton H, Chitty L. Fetal sex determination using free fetal DNA: service users' experiences and preferences for how the service should be offered in clinical practice. Prenat Diagn 2012;32:735-41.
15. Hill M, Compton C, Lewis C, et al. Determination of fetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom. Haemophilia 2012;18:575-83.
16. Kelly SE, Farrimond HR. Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics 2012;15:73-81.
17. Tischler R, Hudgins L, Blumenfeld YJ, et al. Non-invasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;31:1292-9.
18. Kooij L, Tymstra T, Berg P, et al. The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 2009;29:164-8.
19. Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 2011;31:1070-6.
20. Koelewijn JM, Vrijkotte TG, de Haas M, et al. Women's attitudes towards prenatal screening for red blood cell antibodies, other than RhD. BMC Pregnancy Childbirth 2008;8:49-63.